Ignite Creation Date:
2024-05-06 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05258331
Status:
RECRUITING
Last Update Posted:
2022-03-18
First Post:
2022-02-14
Brief Title:
Clinical Trial to Evaluate the Safety Tolerability and Efficacy of CT303 in Patients With Psoriasis
Sponsor:
GC Cell Corporation
Organization:
GC Cell Corporation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Moderate to Severe Plaque Psoriasis |
Keywords:
| Name | View |
|---|---|
| Psoriasis | View |